AHL Partners’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.08M Sell
13,569
-37,616
-73% -$2.99M 0.02% 868
2017
Q3
$3.59M Sell
51,185
-23,969
-32% -$1.52M 0.06% 483
2017
Q2
$4.6M Buy
75,154
+53,466
+247% +$3.02M 0.1% 380
2017
Q1
$1.06M Buy
+21,688
New +$1.05M 0.02% 772
2016
Q3
Sell
-51,439
Closed -$2.58M 1140
2016
Q2
$2.58M Buy
+51,439
New +$2.6M 0.14% 189
2016
Q1
Sell
-37,183
Closed -$2.21M 797
2015
Q4
$2.21M Buy
+37,183
New +$2.26M 0.17% 228

Other funds holding LIVN

AHL Partners's LIVN Position: Q4 2017 in Review

AHL Partners reduced its LivaNova (LIVN) stake by 73% in Q4 2017, selling an estimated $2.99M and leaving 13,569 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #868.

AHL Partners first reported a position in LIVN in Q4 2015 and has held it in 6 quarters since. The position peaked at $4.6M in Q2 2017. 218 funds tracked by Wall St. Rank hold LIVN as of Q4 2017.

  • AHL Partners held 13,569 shares of LivaNova worth $1.08M as of Q4 2017.
  • AHL Partners sold 37,616 LivaNova shares in Q4 2017, an estimated $2.99M.
  • LivaNova made up 0.02% of AHL Partners's portfolio in Q4 2017, its #868 holding.
  • AHL Partners first reported a position in LivaNova in Q4 2015 and has held it in 6 quarters since.
  • AHL Partners's LivaNova position peaked at $4.6M in Q2 2017.
  • 218 funds tracked by Wall St. Rank held LivaNova as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.